PDS Biotechnology (PDSB) announced the appointment of Stephan Toutain, MS, MBA, as Chief Operating Officer, COO, effective as of May 1, 2024. Before joining PDS Biotech, he served as COO at Anavex Life Sciences (AVXL) from May 2018 to April 2024
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDSB:
- PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
- PDS Biotechnology Welcomes Stephan Toutain as New COO
- PDS Biotechnology to host KOL event on Phase 2 VERSATILE-002 trial
- PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
- PDS Biotechnology price target lowered to $11 from $14 at B. Riley